Fig. 1From: Clinically early-stage CSPα mutation carrier exhibits remarkable terminal stage neuronal pathology with minimal evidence of synaptic loss a DNA sequence traces of DNAJC5 Exon 4 of an early stage AD-ANCL patient (top) and wild-type sequence from an age-gender matched control individual (bottom). b Schematic representation of the DNAJC5 gene encoded protein (top) and main transcript (bottom). Mutation p.L115R is highlighted in red.Back to article page